Cargando…
Erratum to: Starting Insulin in Type 2 Diabetes: Real-World Outcomes After the First 12 Months of Insulin Therapy in a New Zealand Cohort
Autores principales: | Sehgal, Shekhar, Khanolkar, Manish |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4374071/ https://www.ncbi.nlm.nih.gov/pubmed/25720340 http://dx.doi.org/10.1007/s13300-015-0102-6 |
Ejemplares similares
-
Starting Insulin in Type 2 Diabetes: Real-World Outcomes After the First 12 Months of Insulin Therapy in a New Zealand Cohort
por: Sehgal, Shekhar, et al.
Publicado: (2015) -
Erratum to “Inositols in the Treatment of Insulin-Mediated Diseases”
por: Muscogiuri, Giovanna, et al.
Publicado: (2016) -
Erratum to: The Economic Burden of Insulin-Related Hypoglycemia in Spain
por: Parekh, Witesh, et al.
Publicado: (2017) -
Erratum to: Differences in metabolic and mitogenic signalling of insulin glargine and AspB10 human insulin in rats
por: Tennagels, N., et al.
Publicado: (2013) -
Erratum to: The gut microbiota profile is associated with insulin action in humans
por: Serino, Matteo, et al.
Publicado: (2012)